Small molecules to treat ALS

Israel’s Neuromagen is developing a new class of small molecules to treat ALS (Amyotrophic Lateral Sclerosis – Lou Gehrig’s Disease), and other neurodegenerative diseases. The molecules activate the enzyme telomerase reverse transcriptase, which protects and rehabilitates neuronal cells.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.